One-Liner
A consumer service where a patient's family records the patient's voice before a throat or vocal-cord surgery, creating a high-quality voice replica they can use during weeks of recovery or permanent voice loss.
AI Thinking Process
Verb Transplant engine: 'body-doubling' from film stunt work transplanted to voice. Record a high-fidelity voice now while healthy; deploy the replica later when voice is compromised by surgery or permanent disease.
Voice body-double for pre-surgery voice banking. Family pays €60-120 to capture patient voice before ENT, thyroid, or laryngectomy surgery. One-time transaction at the pre-op anxiety window.
WHO: adult child of 60+ patient with scheduled voice-affecting surgery. CURRENT: iPhone voice memos or nothing; hospital social workers occasionally point families to ElevenLabs at $11/mo with technical friction. WHY-SURPRISED: SpeechSAVE and ModelTalker serve ALS only. The elective-surgery family-payer angle appeared empty.
SpeechSAVE (UK MND charity, free, slow, ALS-only), ModelTalker (academic, ALS/MND), Acapela My-Own-Voice (B2B AAC devices, £750-1500), VocaliD (enterprise pivot post-acquisition), Microsoft Custom Neural Voice (enterprise, gated). Consumer family-payer for elective surgical recovery appeared empty.
Survived at 42% conviction. Biggest worry: the major AI voice platform ships a hospital partnership within 6-12 months, absorbing the elective-surgery family-payer wedge.
ElevenLabs Impact Program (March 2026) confirmed: $1 billion pledge, free restoration voice technology to 1 million people. Partnerships already signed: Lary's Speakeasy (laryngectomy), Stroke Onward (stroke survivors). Cross-verified from multiple sources. Announced 3 months before this session — the 6-12 month worry materialized early.
UltraVoice2 confirmed: paid consumer-facing voice banking service explicitly framed for pre-surgery preparation. Respeecher confirmed pre-surgery banking case (researcher Konrad Zielinski). Laronix Bionic Voice confirmed. Four independent competitors cross-verified.
FEATURE gate failed. The leading voice AI platform already acquired the customer relationship at charity scale (1M people, $1B commitment). Extending the Impact Program to cover elective-surgery temporary voice loss is a one-sprint product decision for their team.
Conviction revised 42% to 24%. Unit-economics ceiling under €1M ARR even at strong conversion makes the clinical-referral build cost unjustifiable.
Killed in deepening. The consumer-payer wedge was closed by the Impact Program + UltraVoice2 + community nonprofit partnerships combined. Pass 1 correctly identified the risk; verification showed it materialized faster than estimated.
Kill Reason
ElevenLabs Impact Program (March 2026) — a $1 billion pledge offering free voice restoration to one million people with permanent voice loss, with partnerships already signed with laryngectomy and stroke communities — combined with direct competitor UltraVoice2 targeting the pre-surgery consumer case, closed the consumer-payer wedge three months before this session.
AI Self-Correction
↓18pts — confidence dropped after deeper analysis
Risk Analysis
Risk analysis available for latest engine ideas.
Loading...
Related ideas you can explore free:
killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.
killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.
killed: Template epidemic (G003) + industry-pain-form death pattern (G005) fire simultaneously. 13+ existing compliance tools. A prompt could do 80% of this.